Coeptis Therapeutics Holdings, Inc.

NasdaqCM:COEP Stock Report

Market Cap: US$5.8m

Coeptis Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:COEP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Jan 24BuyUS$1,305Tara DeSilvaIndividual2,266US$0.58
10 Jan 24BuyUS$3,350Brian CogleyIndividual5,000US$0.67
08 Jan 24BuyUS$16,747David MehalickIndividual25,054US$0.69
05 Jan 24BuyUS$7,487Daniel YeraceIndividual10,850US$0.69
05 Jan 24BuyUS$8,004Eugene SalkindIndividual11,600US$0.69
05 Jan 24BuyUS$5,390Christopher CochranIndividual7,000US$0.77

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of COEP?
Owner TypeNumber of SharesOwnership Percentage
Institutions5,660,37813.8%
Individual Insiders8,076,89419.6%
General Public27,381,32166.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.6%.

Top Shareholders

Top 25 shareholders own 33.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.33%
David Mehalick
2,601,311US$369.4k0%no data
4.99%
Leonite Capital LLC
2,050,000US$291.1k0%7.46%
4.61%
Armistice Capital LLC
1,895,470US$269.2k-37.5%0.01%
3.49%
Lena Kuchera
1,433,229US$203.5k0%no data
3.49%
Lisa Kuchera
1,433,229US$203.5k0%no data
2.46%
Christine Sheehy
1,010,605US$143.5k0%no data
2.46%
Daniel Yerace
1,010,605US$143.5k0%no data
1.57%
Creative Planning, LLC
645,104US$91.6k0%no data
1.22%
Christopher Calise
503,698US$71.5k0%no data
1.09%
Meteora Capital, LLC
446,251US$63.4k0%0.02%
0.37%
Geode Capital Management, LLC
153,781US$21.8k-22.7%no data
0.27%
Citadel Advisors LLC
111,338US$15.8k0%no data
0.25%
The Vanguard Group, Inc.
100,759US$14.3k0%no data
0.2%
Eugene Salkind
84,217US$12.0k0%no data
0.14%
Cambridge Investment Research Advisors, Inc.
56,149US$8.0k0%no data
0.12%
Arista Wealth Management, LLC
47,332US$6.7k0%no data
0.11%
Mint Tower Capital Management B.V.
45,000US$6.4k0%0.01%
0.095%
UBS Asset Management AG
38,975US$5.5k0%no data
0.077%
Jane Street Group, LLC, Asset Management Arm
31,565US$4.5k125%no data
0.049%
Steward Partners Investment Advisory, LLC
20,000US$2.8k0%no data
0.023%
Tower Research Capital Europe Limited
9,574US$1.4k-0.66%no data
0.021%
Securities America Advisors, Inc.
8,700US$1.2k0%no data
0.00049%
Bank of America Corporation, Asset Management Arm
201US$28.6-6.51%no data
0.00027%
Semmax Financial Advisors, Inc, Asset Management Arm
112US$15.80%no data
0.00016%
Barclays PLC Private Banking & Investment Banking Investment
67US$9.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 01:05
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Coeptis Therapeutics Holdings, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael KingD. Boral Capital LLC.
Aydin HuseynovLadenburg Thalmann & Company